Richard Gregory

Richard Gregory was appointed Chief Scientific Officer and Executive Vice President Research at ImmunoGen, Inc. in January of 2015. Prior to that, Dr. Gregory managed Genzyme Research and Development. His research has appeared in more than 60 publications and he is co-inventor of 23 issued U.S. patents.

Richard is a fellow of the American Institute for Medical and Biological Engineering and also belongs to several professional societies, including the American Society of Gene and Cell Therapy and the American Association for Cancer Research. He earned a Bachelor of Science degree in Biochemistry from Virginia Polytechnic Institute and State University, and a doctorate in Biochemistry from the University of Massachusetts Amherst.